Vitae Arete
Insights & Clinical Perspectives

Evidence meets everyday living.

Clinical perspectives on GLP-1 & weight loss, oncology nutrition, food policy, and lifestyle medicine. Written from the clinical bedside, grounded in peer-reviewed evidence.

25+ Clinical Articles
4 Content Pillars
Weekly New Analyses
Editorial standards

Most clinical writing online is either too dilute to inform a decision or too dense to read on a Tuesday night between meetings. The work here tries to live in the middle: substantive enough that a practicing clinician can use it at the bedside, accessible enough that a patient or executive can read it without a glossary.

Each piece is grounded in peer-reviewed evidence: typically Phase 2/3 trial data, meta-analyses, and the clinical guidelines that flow from them. Where the evidence is contested or incomplete, that gets said explicitly. Where industry marketing has filled gaps the science hasn't yet, that gets said too. The bias here is toward the conservative, “what would I tell my own patient” interpretation, not the maximum-engagement headline.

Four content pillars: GLP-1 & weight loss (the muscle-preservation problem, dosing-day nutrition, plateau strategy, off-cycle planning), oncology nutrition (the most underappreciated quality-of-life lever in active treatment, and where my clinical career began), food and healthcare policy (where workforce structures, supplemental programs, and reimbursement collide with bedside reality), and lifestyle medicine (the boring, evidence-rich interventions that don't get marketing budgets).

Intended for practicing clinicians, allied health professionals, patients navigating complex treatment, healthcare-system leadership trying to make better workforce decisions, and the curious public who'd rather read the underlying data than the headline. Every article cites its primary sources inline so you can follow the trail.

New analyses are published during active research cycles. Topic suggestions, source corrections, and clinical disagreement all welcome at [email protected].

What Does a GLP-1 Dietitian Actually Do?

The drug suppresses appetite; it doesn't tell you what to eat, how to protect muscle, or how to hold your weight after. What a dietitian actually does alongside your prescriber, and when it's worth it.

Read →

Ozempic Face: Why It Happens and How to Prevent It

The gaunt, hollow look isn't the drug aging your skin. It's rapid fat loss showing up in the face first. Why it happens, who's most prone, and how slower loss plus enough protein blunts it.

Read →

Do You Have to Stay on a GLP-1 Forever?

Obesity is a chronic condition, and for many people the medication is long-term, like blood pressure treatment. An honest look at what happens when you stop, who can taper, and how to plan it.

Read →

Compounded vs Brand-Name GLP-1s: What to Know

Compounded semaglutide costs less, but it isn't FDA-approved and quality can vary. A balanced look at the real differences, the questions to ask your prescriber and pharmacist, and how to stay safe.

Read →

Do Continuous Glucose Monitors Help Without Diabetes?

CGMs are marketed to people without diabetes as a window into metabolism. What the readings can and can't tell you, where the evidence is thin, and how to avoid overreacting to a normal glucose spike.

Read →

Executive Nutrition: What High Performers Get Wrong

High performers optimize everything except how they eat during the workday. The common mistakes: skipped meals, caffeine for lunch, late heavy dinners, and the simple fixes that protect energy and focus.

Read →

How to Reverse Prediabetes with Nutrition

Prediabetes (an A1c of 5.7 to 6.4 percent) is often reversible. The evidence-based levers that lower your number: modest weight loss, activity, fiber, and cutting sugary drinks, grounded in the Diabetes Prevention Program.

Read →

Eating Well During Chemotherapy: A Practical Guide

What to eat during chemo, foods for nausea and taste changes, and how to hold your weight with enough protein and calories. Calm, evidence-based guidance to use alongside your oncology team and cancer-center dietitian.

Read →

Ozempic vs Wegovy vs Mounjaro vs Zepbound: A Dietitian's Comparison

Four brands, two molecules. Ozempic and Wegovy are semaglutide; Mounjaro and Zepbound are tirzepatide. A side-by-side comparison table, and the nutrition that decides your result.

Read →

GLP-1 and Hair Loss: Is It the Medication or the Diet?

Finding hair in the drain on Ozempic or Wegovy? The shedding is almost always telogen effluvium, a temporary response to rapid weight loss and nutritional gaps, not damage from the drug, and not permanent. What is happening, and the protein, calorie, and ferritin levers that help.

Read →

Alcohol and GLP-1 Medications: What a Dietitian Wants You to Know

Can you drink on Ozempic, Wegovy, Mounjaro, or Zepbound? Many people want it less, and the real cautions are nausea, blood sugar, empty calories, and hydration. A dietitian's practical guidance.

Read →

What to Eat on a GLP-1: A Dietitian's Complete Guide

The food side of Ozempic, Wegovy, Mounjaro, and Zepbound: protein targets, eating through nausea, fiber and fluids for the GI side effects, protecting against nutrient gaps, and a realistic sample day of eating that works with appetite suppression.

Read →

What to Eat When Ozempic Makes You Nauseous

Nausea is the #1 reason people struggle in the first weeks. The six rules that fix most of it, the foods that go down easily, what to avoid, and when nausea is a red flag worth a call to your prescriber.

Read →

Maintaining Your Weight After Stopping a GLP-1

Most people regain weight after stopping. But it's not inevitable. The dietitian's playbook: protect muscle before you taper, build habits while the drug makes it easier, and plan the off-ramp.

Read →

How to Get Enough Protein on a GLP-1 When You Can Barely Eat

You need more protein, but the drug killed your appetite. Four tactical moves, protein first, density over volume, fortifying, and the no-chew shake, to hit your target on a suppressed appetite.

Read →

GLP-1 Constipation: What to Eat and Drink for Relief

The side effect that lingers after nausea eases. The fiber-and-fluid fix done right, the foods that actually help, when to add magnesium, and the red flag that means call your prescriber.

Read →

What to Eat on Mounjaro or Zepbound (Tirzepatide)

Same drug, same diet, and the largest weight loss of any GLP-1, which makes muscle protection matter most. The tirzepatide-specific guide to protein, side effects, and a plan that lasts.

Read →

GLP-1 “Food Noise” and Food Aversions: What to Do

The medication quiets the constant chatter about food, a relief, but can create aversions and a risk of under-eating. What's happening, and how to eat well when nothing appeals.

Read →

Why I Order Your Labs, and Why DTC Lab Kits Miss the Point

The direct-to-consumer lab market hit $3B in 2024. Here's why clinician-ordered panels remain the standard of care in premium clinical nutrition, and exactly what generic panels miss in real practice.

Read →

The 2× Protein Rule: Why GLP-1 Patients Need Double the Standard Recommendation

The standard 0.8 g/kg protein recommendation was designed to prevent deficiency, not preserve muscle during rapid GLP-1 weight loss. A clinical breakdown of the evidence-based 2× rule and exactly how to hit it when appetite is suppressed, with two interactive charts.

Read →

The Missing Screw: Why Healthcare Gets Rebuilt Every 5 Years While Patients Age Over 50

Healthcare is being designed by people who will never feel the consequences of their designs. An essay on executive short-termism, the hollowing of the clinical workforce, and the load-bearing services quietly optimized away, with five source-cited charts.

Read →

Why 25–39% of Your GLP-1 Weight Loss May Be Muscle, and Exactly How to Stop It

Tirzepatide produces remarkable weight loss, but one-third of it is muscle. The resistance training prescription and protein-timing protocol that stops the bleed.

Read →

Eating Through Immunotherapy: What's Different and Why It Matters

Immunotherapy side effects create a different nutritional landscape than chemotherapy, and most patients aren't prepared for it.

Read →

Retatrutide: What the Phase 2 Data Actually Shows

24.2% mean body weight reduction at 48 weeks. The triple agonist data is extraordinary, and the clinical implications are significant.

Read →

The Anti-Inflammatory Plate: A Blueprint for Metabolic Health

How to structure your meals to reduce chronic inflammation, support metabolic function, and build lasting dietary habits grounded in evidence.

Read →
Newsletter

Clinical nutrition writing, published monthly. Evidence over opinion.